Bankwell Financial insider to sell 1,985 shares

Accepted by SEC EDGAR 02/09/2026 - 04:19 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Bankwell Financial Group, Inc. received a notice that a shareholder plans to sell 1,985 shares of its common stock under Rule 144. The shares, valued at an aggregate market price of $98,852.00, are to be sold through Citigroup Global Markets on NASDAQ around February 9, 2026.

The shares come from restricted stock that vested on February 9, 2026, as compensation from Bankwell Financial Group, Inc. The filing also notes that Christine Chivily sold 2,533 common shares on November 12, 2025, generating gross proceeds of $116,164.21.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the BWFG Form 144 filing disclose about planned share sales?

The filing discloses a planned sale of 1,985 Bankwell Financial Group, Inc. common shares under Rule 144. These shares have an aggregate market value of $98,852.00 and are expected to be sold through Citigroup Global Markets on NASDAQ around February 9, 2026.

How were the Bankwell Financial (BWFG) shares being sold under Form 144 acquired?

The 1,985 shares of Bankwell Financial Group, Inc. common stock were acquired through restricted stock vesting on February 9, 2026. The shares were received from Bankwell Financial Group, Inc. as compensation, rather than purchased for cash in the open market.

Which broker will handle the BWFG Rule 144 share sale and on which exchange?

The planned sale of 1,985 Bankwell Financial Group, Inc. common shares will be handled by Citigroup Global Markets, Inc., based at 390 Greenwich St, New York. The filing states that the shares are expected to be sold on the NASDAQ stock exchange.

What prior BWFG share sales are reported in the Form 144 filing?

The filing reports that Christine Chivily sold 2,533 Bankwell Financial common shares on November 12, 2025. Those sales generated $116,164.21 in gross proceeds, and they are disclosed as securities sold during the past three months for aggregation under Rule 144.

What is the relationship between the BWFG Form 144 filing and Rule 10b5-1 plans?

The form explains that if the seller uses a written trading plan or instructions under Rule 10b5-1, signing the notice represents they lacked undisclosed material adverse information as of the plan or instruction date, aligning the sale with insider trading safeguards in securities regulations.

What representation does the BWFG Form 144 seller make about company information?

By signing the notice, the person for whose account the securities are sold represents they do not know any material adverse information about Bankwell Financial Group, Inc.’s current or prospective operations that has not been publicly disclosed, as required under the Rule 144 framework.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001665699
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Bankwell Financial Group, Inc.
SEC File Number	001-36448
Address of Issuer	208 ELM STREET NEW CANAAN CONNECTICUT 06840
Phone	(203) 972-3838
Name of Person for Whose Account the Securities are To Be Sold	Chivily Christine
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	EVP & Chief Credit Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Citigroup Global Markets, Inc 390 Greenwich St New York NY 10013	1985	98852.00	7877443	02/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/09/2026	Restricted stock vesting	Bankwell Financial Group, Inc.			1985	02/09/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Christine Chivily 208 ELM STREET NEW CANAAN CT 06840	Common	11/12/2025	2533	116164.21

144: Remarks and Signature

Remarks	shares were sold to cover tax obligations arising from the vesting of restricted stock
Date of Notice	02/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Conformed Signature On File
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)